Prevention of Breast Cancer by Food Bioactives in Relation to Cancer Subtypes: Epigenetic Mechanisms

Research output: Chapter in Book/Report/Conference proceedingChapter

2 Scopus citations

Abstract

Breast cancer is the most common type of cancer and the leading cause of mortality among women worldwide. Aberrations in epigenetic regulation of tumor-suppressor genes contribute to hereditary and sporadic breast cancers. Accumulating evidence suggests a role for dietary compounds as epigenetic modifiers of breast cancer risk. However, given that breast cancer is a heterogeneous disease, it is important to consider variations in the epigenetic profile and potential response to food compounds across breast cancer subtypes. In this chapter, we first summarize research evidence regarding differences in epigenotype across breast tumor subtypes with emphasis on changes in DNA methylation, histone modifications, and the expression of noncoding RNA. Second, we discuss the role of epigenetic mechanisms in the silencing of breast cancer 1 (BRCA1), selected as a prototype early-onset breast cancer gene and epigenetic target by environmental and endogenous compounds that activate the aryl hydrocarbon receptor (AhR). Third, we highlight research evidence about food components (e.g., resveratrol and genistein) as dietary preventatives against epigenetic repression of BRCA1 by AhR agonists and the development of estrogen receptor-negative and triple-negative breast cancer.

Original languageEnglish (US)
Title of host publicationEpigenetics of Cancer Prevention
PublisherElsevier
Pages309-332
Number of pages24
ISBN (Electronic)9780128124949
DOIs
StatePublished - Jan 1 2018

Keywords

  • Aryl hydrocarbon receptor
  • BRCA1
  • Breast cancer
  • DNA methylation
  • Diet
  • Epigenetics
  • Histone posttranslational modifications
  • Noncoding RNA

ASJC Scopus subject areas

  • Medicine(all)
  • Biochemistry, Genetics and Molecular Biology(all)

Fingerprint

Dive into the research topics of 'Prevention of Breast Cancer by Food Bioactives in Relation to Cancer Subtypes: Epigenetic Mechanisms'. Together they form a unique fingerprint.

Cite this